株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中国の分子診断市場・検査件数の予測

China Molecular Diagnostics Market, Test Volume & Forecast By Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer) Infectious Disease Test (Virology, HPV), Genetic Test (Blood Screening, HLA)

発行 Renub Research 商品コード 344768
出版日 ページ情報 英文 105 Pages; 55 Figures; 14 Tables
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.24円で換算しております。
Back to Top
中国の分子診断市場・検査件数の予測 China Molecular Diagnostics Market, Test Volume & Forecast By Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer) Infectious Disease Test (Virology, HPV), Genetic Test (Blood Screening, HLA)
出版日: 2017年08月28日 ページ情報: 英文 105 Pages; 55 Figures; 14 Tables
概要

当レポートでは、中国の分子診断の市場について調査し、市場規模および検査件数の推移と予測、用途別の詳細分析、市場成長の推進因子および課題の分析、主要事業者のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 中国の分子診断市場・検査件数の予測

  • 中国の分子診断市場の推移と予測
  • 中国の分子診断検査件数の推移と予測

第3章 中国の分子診断市場・検査件数によるシェアの分析

  • 中国の分子診断市場のシェア:推移と予測
  • 用途別シェアの推移と予測
  • 中国の分子診断の検査件数によるシェア:推移と予測
  • 検査件数能登用途別シェア:推移と予測

第4章 中国の分子診断検査件数の推移と予測:用途別

  • 癌の分子診断検査件数のシェア:推移と予測
  • 癌検査件数の推移と予測
    • 乳癌
    • 直腸癌
    • 前立腺癌
  • 感染症の分子診断検査件数のシェア:推移と予測
  • 感染症検査件数の推移と予測
    • ウイルス検査
    • HPV検査
  • 遺伝子の分子検査件数のシェア:推移と予測
  • 遺伝子検査件数の推移と予測
    • 血液スクリーニング検査
    • HLA検査

第5章 中国の分子診断市場の予測:用途別

  • 癌の分子診断検査市場のシェア:推移と予測
  • 癌検査市場の推移と予測
    • 乳癌
    • 直腸癌
    • 前立腺癌
  • 感染症の分子診断検査市場のシェア:推移と予測
  • 感染症検査市場の推移と予測
    • ウイルス検査
    • HPV検査
  • 遺伝子の分子診断検査市場のシェア:推移と予測
  • 遺伝子検査市場の推移と予測
    • 血液スクリーニング検査
    • HLA検査

第6章 成長推進因子

第7章 課題

第8章 主な民間臨床ラボ・診断サービス企業のプロファイル

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

China molecular diagnostics market is growing at a fast pace owing to rising prevalence of infectious diseases and cancer cases in the region coupled with growing geriatric population. It is projected that China molecular diagnostics market will exceed US$ 1.5 Billion by the end of 2022. Molecular diagnostics are extremely effective in diagnosing and preventing diseases, offering accurate and precise healthcare interventions in the early stages of diseases.

China Molecular Diagnostics Segments Market

China molecular diagnostics market has been segmented into three major categories: Oncology Testing, Infectious Disease Testing and Genetic Disease Testing. Further, Oncology Testing has been segmented into three major categories: Breast Cancer Testing, Colorectal Cancer Testing and Prostate Cancer Testing. Infectious Disease Testing has been segmented into two major categories, namely, virology and HPV and Genetic Testing has been segmented into Blood Screening and HLA.

China Infectious Disease test market; Virology tests accounts for the highest market share. Furthermore, our analysis found that nearly 300 million molecular diagnostic tests will be performed in China by the end of 2022 of which Virology accounts for one of the most performed tests segments.

Increasing incidence of contagious diseases along with cancer cases and the rise of the private healthcare sector in China, with the development of socio-economic conditions and the growth of a wealthy middle class, has increased the quest for affordable and quality healthcare across the region are some of the contributors which are anticipated to drive the molecular diagnostics market over the forecast period.

This is the 5th report on Molecular Diagnostics industry published by Renub Research. This report titled "China Molecular Diagnostics Market, Test Volume & Forecast by Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer) Infectious Disease Test (Virology, HPV), Genetic Test (Blood Screening, HLA) " provides a comprehensive assessment of the fast-evolving, high-growth China Molecular diagnostics market. This 105 page report with 55 Figures and 14 Tables studies the China Molecular Diagnostic market from 4 view points:

  • 1. Market & Forecast
  • 2. Molecular Diagnostics Segments Market & Forecast
  • 3. Molecular Diagnostics Segments Test Volume & Forecast
  • 4. Profiles of Select Private Clinical Labs & Diagnostic Services Companies

Segments Covered in this report are as follows:

Oncology Test Market and Volume

  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer

Infectious Disease Test Market and Volume

  • Virology
  • HPV

Genetic Test Market and Volume

  • Blood Screening
  • HLA

Key Players Analysis

  • Zhejiang Di'an Diagnostics Technology Co., Ltd.
  • ADICON Clinical Laboratories (Privately held)
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global (Privately held)
  • BGI-Shenzhen
  • OriGene Technologies

Key questions answered in the study

  • What is China molecular diagnostics market size from 2011 to 2022?
  • What is China molecular diagnostics tests volume from 2011 to 2022?
  • What are China molecular diagnostics segments market & Forecast?
  • What are the growth drivers of Molecular diagnostics in China?

Table of Contents

1. Research Findings

2. China Molecular Diagnostic Market & Test Volume Forecast

  • 2.1 China Molecular Diagnostic Market
  • 2.2 China Molecular Diagnostic Test Volume

3. China Molecular Diagnostic Market Share Analysis

  • 3.1 Market Share - (Oncology, Infectious, Genetic) Testing
  • 3.2 Market Share - Segments (Breast, Colorectal, Prostate, Virology, HPV, Blood Screening, HLA) Cancer Tests

4. China Molecular Diagnostic Volume Share (2011 - 2022)

  • 4.1 Volume Share - (Oncology, Infectious, Genetic) Testing
  • 4.2 Volume Share - Segments (Breast, Colorectal, Prostate, Virology, HPV, Blood Screening, HLA) Cancer Tests

5. Segments Test Volume - China Molecular Diagnostics

  • 5.1 Volume Share - (Breast, Colorectal, Prostate) Oncology Test
  • 5.2 Oncology Test Volume
    • 5.2.1 Breast Cancer Test Volume
    • 5.2.2 Colorectal Cancer Test Volume
    • 5.2.3 Prostate Cancer Test Volume
  • 5.3 Volume Share - (Virology, HPV) Infectious Disease Test
  • 5.4 Infectious Disease Test Volume
    • 5.4.1 Virology Test Volume
    • 5.4.2 HPV Test Volume
  • 5.5 Volume Share - (Blood Screening, HLA) Genetic Test
  • 5.6 Genetic Test Volume
    • 5.6.1 Blood Screening Test Volume
    • 5.6.2 HLA Test Volume

6. Segments Test Market - China Molecular Diagnostics Market (2011 - 2022)

  • 6.1 Market Share - (Breast, Colorectal, Prostate) Oncology Test
  • 6.2 Oncology Test Market
    • 6.2.1 Breast Cancer Test Market
    • 6.2.2 Colorectal Cancer Test Market
    • 6.2.3 Prostate Cancer Test Market
  • 6.3 Market Share - (Virology, HPV) Infectious Disease Test
  • 6.4 Infectious Disease Test Market
    • 6.4.1 Virology Test Market
    • 6.4.2 HPV Test Market
  • 6.5 Market Share - (Blood Screening, HLA) Genetic Test
  • 6.6 Genetic Test Market
    • 6.6.1 Blood Screening Market
    • 6.6.2 HLA Test Market

7. China Healthcare Insurance Schemes

  • 7.1 China Healthcare Insurance Schemes
    • 7.1.1 NRCMS
    • 7.1.2 UEBMI
    • 7.1.3 URBMI
    • 7.1.4 Private Health Insurance
    • 7.1.5 Cost-sharing and out-of-pocket Spending

8. Growth Drivers

  • 8.1 Rising Order for High Quality Healthcare Products
  • 8.2 Growing Cases of Lifestyle Diseases
  • 8.3 Rapid Diagnosis of Infectious Diseases
  • 8.4 Rise in Number of Private Hospitals & Independent Diagnostics Clinics
    • 8.4.1 Rise in the Number of Hospital Beds across all Medical Institutions
  • 8.5 Increasing Automation

9. Challenges

  • 9.1 Nil Government Support & Public Awareness
  • 9.2 Dearth of Trained Medical Technicians
  • 9.3 Reimbursement Rates differ from Province to Province in China
    • 9.3.1 Chinese Government Regulating Laboratory Testing in China

10. Profiles of Select Private Clinical Labs and Diagnostic Services Companies

  • 10.1 Zhejiang Di'an Diagnostics Technology Co., Ltd.
    • 10.1.1 Company Overview
    • 10.1.2 Products and Services Offered by Di'an
  • 10.2 ADICON Clinical Laboratories (Privately held)
    • 10.2.1 Company Overview
    • 10.2.2 Products and Services Offered by ADICON
  • 10.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
    • 10.3.1 Company Overview
    • 10.3.2 Products and Services Offered by Kingmed
  • 10.4 Kindstar Global (Privately held)
    • 10.4.1 Company Overview
    • 10.4.2 Products and Services Offered by Kindstar
  • 10.5 BGI-Shenzhen
    • 10.5.1 Company Overview
    • 10.5.2 BGI's Innovative Approach
  • 10.6 OriGene Technologies
    • 10.6.1 Company Overview
    • 10.6.2 Products and Services Offered by OriGene

List of Figures

  • Figure 2-1: China - Molecular Diagnostic Market (Million US$), 2011 - 2016
  • Figure 2-2: China - Forecast for Molecular Diagnostic Market (Million US$), 2017 - 2022
  • Figure 2-3: China - Molecular Diagnostic Test Volume (Million), 2011 - 2016
  • Figure 2-4: China - Forecast for Molecular Diagnostic Test Volume (Million), 2017 - 2022
  • Figure 3-1: China - Molecular Diagnostic Market Share (Percent), 2011 - 2016
  • Figure 3-2: China - Forecast for Molecular Diagnostic Market Share (Percent), 2017 - 2022
  • Figure 3-5: China - Molecular Diagnostic Test Volume Share (Percent), 2011 - 2016
  • Figure 3-6: China - Forecast for Molecular Diagnostic Test Volume Share (Percent), 2017 - 2022
  • Figure 4-1: China - Molecular Oncology Test Volume Share (Percent), 2011 - 2016
  • Figure 4-2: China - Forecast for Molecular Oncology Test Volume Share (Percent), 2017 - 2022
  • Figure 4-3: Rural China - Cancer Screening Sites by Cancer Type (Number), 2013
  • Figure 4-4: China - Oncology Test Volume (Million), 2011 - 2016
  • Figure 4-5: China - Forecast for Oncology Test Volume (Million), 2017 - 2022
  • Figure 4-6: China -Breast Cancer Molecular Test Volume (Million), 2011 - 2016
  • Figure 4-7: China - Forecast for Breast Cancer Molecular Test Volume (Million), 2017 - 2022
  • Figure 4-8: China -Colorectal Cancer Test Volume (Million), 2011 - 2016
  • Figure 4-9: China - Forecast for Colorectal Cancer Test Volume (Million), 2017 - 2022
  • Figure 4-10: China -Prostate Cancer Test Volume (Million), 2011 - 2016
  • Figure 4-11: China - Forecast for Prostate Cancer Test Volume (Million), 2017 - 2022
  • Figure 4-14: China -Infectious Disease Test Volume (Million), 2011 - 2016
  • Figure 4-15: China - Forecast for Infectious Disease Test Volume (Million), 2017 - 2022
  • Figure 4-16: China -Virology Test Volume (Million), 2011 - 2016
  • Figure 4-17: China - Forecast for Virology Test Volume (Million), 2017 - 2022
  • Figure 4-18: China -HPV Test Volume (Thousand), 2011 - 2016
  • Figure 4-19: China - Forecast for HPV Test Volume (Thousand), 2017 - 2022
  • Figure 4-22: China -Genetic Test Volume (Million), 2011 - 2016
  • Figure 4-23: China - Forecast for Genetic Test Volume (Million), 2017 - 2022
  • Figure 4-24: China -Blood Screening Test Volume (Million), 2011 - 2016
  • Figure 4-25: China - Forecast for Blood Screening Test Volume (Million), 2017 - 2022
  • Figure 4-26: China - HLA Test Volume (Thousand), 2011 - 2016
  • Figure 4-27: China - Forecast for HLA Test Volume (Thousand), 2017 - 2022
  • Figure 5-1: China - Molecular Oncology Test Market Share (Percent), 2011 - 2016
  • Figure 5-2: China - Forecast for Molecular Oncology Test Market Share (Percent), 2017 - 2022
  • Figure 5-3: China -Oncology Test Market (Million US$), 2011 - 2016
  • Figure 5-4: China - Forecast for Oncology Test Market (Million US$), 2017 - 2022
  • Figure 5-5: China -Breast Cancer Test Market (Million US$), 2011 - 2016
  • Figure 5-6: China - Forecast for Breast Cancer Test Market (Million US$), 2017 - 2022
  • Figure 5-7: China -Colorectal Cancer Test Market (Million US$), 2011 - 2016
  • Figure 5-8: China - Forecast for Colorectal Cancer Test Market (Million US$), 2017 - 2022
  • Figure 5-9: China -Prostate Cancer Testing Market (Million US$), 2011 - 2016
  • Figure 5-10: China - Forecast for Prostate Cancer Testing Market (Million US$), 2017 - 2022
  • Figure 5-13: China -Infectious Disease Test Market (Million US$), 2011 - 2016
  • Figure 5-14: China - Forecast for Infectious Disease Test Market (Million US$), 2017 - 2022
  • Figure 5-15: China -Virology Test Market (Million US$), 2011 - 2016
  • Figure 5-16: China - Forecast for Virology Test Market (Million US$), 2017 - 2022
  • Figure 5-17: China -HPV Test Market (Million US$), 2011 - 2016
  • Figure 5-18: China - Forecast for HPV Test Market (Million US$), 2017 - 2022
  • Figure 5-21: China -Genetic Testing Market (Million US$), 2011 - 2016
  • Figure 5-22: China - Forecast for Genetic Testing Market (Million US$), 2017 - 2022
  • Figure 5-23: China -Blood Screening Market (Million US$), 2011 - 2016
  • Figure 5-24: China - Forecast for Blood Screening Market (Million US$), 2017 - 2022
  • Figure 5-25: China - HLA Test Market (Thousand US$), 2011 - 2016
  • Figure 5-26: China - Forecast for HLA Test Market (Thousand US$), 2017 - 2022
  • Figure 6-1: China - Healthcare Spending (Billion US$), 2011 &2020
  • Figure 8-1: Kindstar - Collaboration with Hospitals in China (Number), 2006-2012

List of Tables

  • Table 3-1: China - Molecular Diagnostic Application Market Share (Percent), 2011 - 2016
  • Table 3-2: China - Forecast for Molecular Diagnostic Application Market Share (Percent), 2017 - 2022
  • Table 3-3: China - Molecular Diagnostic Test Volume Application Share (Percent), 2011 - 2016
  • Table 3-4: China - Forecast for Molecular Diagnostic Test Volume Application Share (Percent), 2017 - 2022
  • Table 4-1: China - Molecular Infectious Disease Test Volume Share (Percent), 2011 - 2016
  • Table 4-2: China - Forecast for Molecular Infectious Disease Test Volume Share (Percent), 2017 - 2022
  • Table 4-3: China - Molecular Genetic Test Volume Share (Percent), 2011 - 2016
  • Table 4-4: China - Forecast for Molecular Genetic Test Volume Share (Percent), 2017 - 2022
  • Table 5-1: China - Molecular Infectious Disease Test Market Share (Percent), 2011 - 2016
  • Table 5-2: China - Forecast for Molecular Infectious Disease Test Market Share (Percent), 2017 - 2022
  • Table 5-3: China - Molecular Genetic Test Market Share (Percent), 2011 - 2016
  • Table 5-4: China - Forecast for Molecular Genetic Test Market Share (Percent), 2017 - 2022
  • Table 6-1: China - Major Diagnostic Reagent R&D and Manufacturing Companies in Infectious Diseases, 2010
  • Table 8 1: Number of Hospital Beds for every 1,000 people
Back to Top